Trial NCT05493501

View at ClinicalTrials.gov 
Org. Study IDs: EQ143-301
Secondary IDs: 2022-002674-93

Last trial update was posted on 2023-10-06

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Gemcitabine Osimertinib Paclitaxel Pemetrexed

MeSH Conditions


Other Conditions

NSCLC

Stopping Reasons

The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with aumolertinib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID